The silver cation (Ag+): Antistaphylococcal activity, mode of action and resistance studies

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 1, 2013, Pages 131-138

  Randall, Christopher P ^a   Oyama, Linda B ^a   Bostock, Julieanne M ^a   Chopra, Ian ^a   O'Neill, Alex J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Antimicrobial susceptibility; Heavy metal resistance; Staphylococcus spp.

Indexed keywords

ANTIBIOTIC AGENT; SILVER; SILVER NITRATE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIABILITY; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BIOFILMS; CULTURE MEDIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SILVER NITRATE; STAPHYLOCOCCUS AUREUS;

EID: 84871245127     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks372     Document Type: Article

References (51)

1. Atiyeh BS, Costagliola M, Hayek SN et al. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007; 33: 139-48.
2. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 2004; 30 Suppl 1: S1-9.
3. Mullick S, Watson-Jones D, Beksinska M et al. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect 2005; 81: 294-302.
4. NHS National Prescribing Centre. Evidence-based prescribing of advanced wound dressings for chronic wounds in primary care. MeReC Bulletin 2010; 21: 1-7.
5. GFMS. The Future of Silver Industrial Demand. March 2011. http://www.silverinstitute.org/images/stories/silver/PDF/futuresilverindustrialdemand.pdf (8 September 2011, date last accessed).
6. Edwards-Jones V. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol 2009; 49: 147-52.
7. Nakane T, Gomyo H, Sasaki I et al. New antiaxillary odour deodorant made with antimicrobial Ag-zeolite (silver-exchanged zeolite). Int J Cosmet Sci 2006; 28: 299-309.
8. Heidarpour F, Ghani W, Bin Ahmadun FR et al. Nano silver-coated polypropylene water filter: ii. Evaluation of antimicrobial efficiency. Dig J Nanomater Biostruct 2010; 5: 797-804.
9. Vimala K, Mohan YM, Sivudu KS et al. Fabrication of porous chitosan films impregnated with silver nanoparticles: a facile approach for superior antibacterial application. Colloid Surf B: Biointerfaces 2010; 76: 248-58.
10. Holt KB, Bard AJ. Interaction of silver(I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 2005; 44: 13214-23.
11. Gordon O, Vig Slenters T, Brunetto PS et al. Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 2010; 54: 4208-18.
12. Park HJ, Kim JY, Kim J et al. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res 2009; 43: 1027-32.
13. Ip M, Lui SL, Chau SS et al. The prevalence of resistance to silver in a burns unit. J Hosp Infect 2006; 63: 342-4.
14. Maple PA, Hamilton-Miller JM, Brumfitt W. Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1992; 29: 661-8.
15. Ug A, Ceylan O. Occurrence of resistance to antibiotics, metals, and plasmids in clinical strains of Staphylococcus spp. Arch Med Res 2003; 34: 130-6.
16. Matsumura Y, Yoshikata K, Kunisaki S et al. Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 2003; 69: 4278-81.
17. McHugh GL, Moellering RC, Hopkins CC et al. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet 1975; i: 235-40.
18. Gupta A, Matsui K, Lo JF et al. Molecular basis for resistance to silver cations in Salmonella. Nat Med 1999; 5: 183-8.
19. Silver S, Phung Le T, Silver G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol 2006; 33: 627-34.
20. + and are deficient in porins. J Bacteriol 1997; 179: 6127-32.
21. Lok CN, Ho CM, Chen R et al. Proteomic identification of the Cus system as a major determinant of constitutive Escherichia coli silver resistance of chromosomal origin. J Proteome Res 2008; 7: 2351-6.
22. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically- Ninth Edition: Approved Standard M07-A9. CLSI, Wayne, PA, USA, 2012.
23. Ooi N, Miller K, Randall C et al. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. J Antimicrob Chemother 2010; 65: 72-8.
24. Ooi N, Miller K, Hobbs J et al. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. J Antimicrob Chemother 2009; 64: 735-40.
25. O'Neill AJ, Miller K, Oliva B et al. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. J Antimicrob Chemother 2004; 54: 1127-9.
26. Hobbs JK, Miller K, O'Neill AJ et al. Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. J Antimicrob Chemother 2008; 62: 1003-8.
27. Hilliard JJ, Goldschmidt RM, Licata L et al. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother 1999; 43: 1693-9.
28. Mariner KR, Ooi N, Roebuck D et al. Further characterization of Bacillus subtilis antibiotic biosensors and their use for antibacterial mode-of-action studies. Antimicrob Agents Chemother 2011; 55: 1784-6.
29. Braet F, De Zanger R, Wisse E. Drying cells for SEM, AFM and TEM by hexamethyldisilazane: a study on hepatic endothelial cells. J Microsc 1997; 186: 84-7.
30. O'Neill AJ, Cove JH, Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647-50.
31. Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 2137-45.
32. Gupta A, Maynes M, Silver S. Effects of halides on plasmid-mediated silver resistance in Escherichia coli. Appl Environ Microbiol 1998; 64: 5042-5.
33. Liau SY, Read DC, Pugh WJ et al. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol 1997; 25: 279-83.
34. Brown EM, Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 2002; 359: 803.
35. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-8.
36. James GA, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
37. Ruhr E, Sahl HG. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother 1985; 27: 841-5.
38. Hurdle JG, O'Neill AJ, Ingham E et al. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques. Antimicrob Agents Chemother 2004; 48: 4366-76.
39. Price CT, Gustafson JE. Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate. J Med Microbiol 2001; 50: 104-6.
40. Chopra I. The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 2007; 59: 587-90.
41. Hurdle JG, O'Neill AJ, Chopra I et al. Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections. Nat Rev Microbiol 2011; 9: 62-75.
42. O'Neill AJ. Bacterial phenotypes refractory to antibiotic-mediated killing: mechanisms and mitigation. In: Miller AA, Miller PF, eds. Emerging Trends in Antibacterial Discovery: Answering the Call to Arms. Norwich: Caister Academic Press, 2011; 195-210.
43. Chaw KC, Manimaran M, Tay FE. Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2005; 49: 4853-9.
44. Posluszny JA Jr, Conrad P, Halerz M et al. Surgical burn wound infections and their clinical implications. J Burn Care Res 2011; 32: 324-33.
45. Rezaei E, Safari H, Naderinasab M et al. Common pathogens in burn wound and changes in their drug sensitivity. Burns 2011; 37: 804-6.
46. Horsburgh MJ, Aish JL, White IJ et al. sB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 2002; 184: 5457-67.
47. O'Neill AJ. Staphylococcus aureus SH1000 and 8325-4: comparative genome sequences of key laboratory strains in staphylococcal research. Lett Appl Microbiol 2010; 51: 358-61.
48. Holden MT, Feil EJ, Lindsay JA et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004; 101: 9786-91.
49. Baba T, Ara T, Hasegawa M et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2: 2006.0008.
50. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
51. Urban A, Eckermann S, Fast B et al. Novel whole-cell antibiotic biosensors for compound discovery. Appl Environ Microbiol 2007; 73: 6436-43.